You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
丽珠医药(01513.HK)收购丽珠生物股权并增资
阿思达克 01-11 18:01
丽珠医药(01513.HK)公布,为实现重组框架协议,公司与健康元分别与丽珠香港签订了股权转让协议,双方同意分别以2,431.6万元人民币(下同)对应认缴出资额1.275亿元)及2,336.3万元福对应认缴出资额1.225亿元)的价格,向丽珠香港收购丽珠生物51%及49%的股权。

另外,公司、健康元、丽生聚源与丽珠生物签订了增资协议,丽珠生物的注册资本由2.5亿元增加至6.67亿元,其中公司认缴1.785亿元的出资额。增资完成後,丽珠生物将分别由公司、健康元及丽生聚源持有45.90%、44.10%及10%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account